Methods and compositions for treating an angiotensinogen(AGT-) associated disorder

PH12022551158B1Active Publication Date: 2026-11-06ALNYLAM PHARMACEUTICALS INC
0 Cites 0 Cited by

Patent Information

Application Number
PH12022551158
Authority / Receiving Office
PH · PH
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-05-12
Publication Date
2026-11-06
Estimated Expiration
2042-05-12
Patent Text Reader

Abstract

The present invention relates to methods of inhibiting the expression of an AGT gene in a subject, as well as methods for treating subjects having an AGTassociated disorder, e.g., hypertension, using RNAi agents, e.g., double stranded RNAi agents, targeting the AGT gene. The invention also relates to methods of decreasing blood pressure levels in a subject using such RNAi agents to inhibit expression of an AGT gene.
Need to check novelty before this filing date? Find Prior Art